- Home
- HSCS vs GIXI Comparison
HSCS vs GIXI Comparison
Compare HSCS & GIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.44
N/A
Current Price
$5.32
Company Overview
Basic Information| Metric | HSCS | GIXI |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 14.6M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | HSCS | GIXI |
|---|---|---|
| Price | $3.44 | $5.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 136.9K | 31.9K |
| Earning Date | 03-16-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,319.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.63 | $4.92 |
| 52 Week High | $4.35 | $6.25 |
Technical Indicators
Market Signals| Indicator | HSCS | GIXI |
|---|---|---|
| Relative Strength Index (RSI) | 57.75 | 32.60 |
| Support Level | $1.88 | $4.92 |
| Resistance Level | $3.57 | $5.81 |
| Average True Range (ATR) | 0.35 | 0.54 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 39.01 | 28.60 |
Price Performance
Historical Comparison HSCS
GIXI
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.